The effect of pore diameter on neo-tissue formation in electrospun biodegradable tissue-engineered arterial grafts in a large animal model

被引:35
|
作者
Matsuzaki, Yuichi [1 ]
Iwaki, Ryuma [1 ]
Reinhardt, James W. [1 ]
Chang, Yu-Chun [1 ,2 ]
Miyamoto, Shinka [1 ]
Kelly, John [1 ]
Zbinden, Jacob [1 ,3 ]
Blum, Kevin [1 ,3 ]
Mirhaidari, Gabriel [1 ,2 ]
Ulziibayar, Anudari [1 ]
Shoji, Toshihiro [1 ]
Breuer, Christopher K. [1 ,4 ]
Shinoka, Toshiharu [1 ,4 ,5 ]
机构
[1] Nationwide Childrens Hosp, Abigail Wexner Res Inst, Ctr Regenerat Med, Columbus, OH 43205 USA
[2] Ohio State Univ, Coll Med, Biomed Sci Grad Program, Columbus, OH 43210 USA
[3] Ohio State Univ, Biomed Engn Grad Program, Columbus, OH 43210 USA
[4] Ohio State Univ, Nationwide Childrens Hosp, Dept Surg, Columbus, OH 43210 USA
[5] Nationwide Childrens Hosp, Heart Ctr, Dept Cardiothorac Surg, 700 Childrens Dr,T2294, Columbus, OH 43205 USA
关键词
Tissue engineering; Vascular graft; Biodegradable; Artery; Pore diameter; Large animal model; VASCULAR GRAFTS; POLARIZATION; FIBERS;
D O I
10.1016/j.actbio.2020.08.011
中图分类号
R318 [生物医学工程];
学科分类号
0831 ;
摘要
To date, there has been little investigation of biodegradable tissue engineered arterial grafts (TEAG) using clinically relevant large animal models. The purpose of this study is to explore how pore size of electrospun scaffolds can be used to balance neoarterial tissue formation with graft structural integrity under arterial environmental conditions throughout the remodeling process. TEAGs were created with an outer poly-epsilon-caprolactone (PCL) electrospun layer and an inner sponge layer composed of heparin conjugated 50:50 poly (l-lactide-co-epsilon-caprolactone) copolymer (PLCL). Outer electrospun layers were created with four different pore diameters (4, 7, 10, and 15 mu m). Fourteen adult female sheep underwent bilateral carotid artery interposition grafting (n = 3-4 /group). Our heparin-eluting TEAG was implanted on one side (n = 14) and ePTFE graft (n = 3) or non-heparin-eluting TEAG (n = 5) on the other side. Twelve of the fourteen animals survived to the designated endpoint at 8 weeks, and one animal with 4 mu m pore diameter graft was followed to 1 year. All heparin-eluting TEAGs were patent, but those with pore diameters larger than 4 mu m began to dilate at week 4. Only scaffolds with a pore diameter of 4 mu m resisted dilation and could do so for up to 1 year. At 8 weeks, the 10 mu m pore graft had the highest density of cells in the electrospun layer and macrophages were the primary cell type present. This study highlights challenges in designing bioabsorbable TEAGs for the arterial environment in a large animal model. While larger pore diameter TEAGs promoted cell infiltration, neotissue could not regenerate rapidly enough to provide sufficient mechanical strength required to resist dilation. Future studies will be focused on evaluating a smaller pore design to better understand long-term remodeling and determine feasibility for clinical use. Statement of Significance In situ vascular tissue engineering relies on a biodegradable scaffold that encourages tissue regeneration and maintains mechanical integrity until the neotissue can bear the load. Species-specific differences in tissue regeneration and larger mechanical forces often result in graft failure when scaling up from small to large animal models. This study utilizes a slow-degrading electrospun PCL sheath to reinforce a tissue engineered arterials graft. Pore size, a property critical to tissue regeneration, was controlled by changing PCL fiber diameter and the resulting effects of these properties on neotissue formation and graft durability was evaluated. This study is among few to report the effect of pore size on vascular neotissue formation in a large animal arterial model and also demonstrate robust neotissue formation. (C) 2020 Acta Materialia Inc. Published by Elsevier Ltd. All rights reserved.
引用
收藏
页码:176 / 184
页数:9
相关论文
共 50 条
  • [1] Characterization of small-diameter electrospun tissue-engineered arterial grafts
    Mirensky, Tamar L.
    Fein, Corey W.
    Nguyen, Gerard K.
    Hibino, Narutoshi
    Sawh-Martinez, Rajendra F.
    Yi, Tai
    McGillicuddy, Edward A.
    Villalona, Gustavo
    Shinoka, Toshiharu
    Breuer, Christopher K.
    JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS, 2009, 209 (03) : S30 - S30
  • [2] Balancing Scaffold Degradation and Neo-Tissue Formation in In Situ Tissue Engineered Vascular Grafts
    Uiterwijk, Marcelle
    Coolen, Bram F.
    van Rijswijk, Jan-Willem
    Soentjens, Serge H. M.
    van Houtem, Michel H. C. J.
    Szymczyk, Wojciech
    Rijns, Laura
    Janssen, Henk M.
    van de Wal, Allard
    de Mol, Bas A. J. M.
    Bouten, Carlijn V. C.
    Strijkers, Gustav J.
    Dankers, Patricia Y. W.
    Kluin, Jolanda
    TISSUE ENGINEERING PART A, 2024, 30 (15-16) : 421 - 436
  • [3] Tissue-engineered vascular grafts for small-diameter arterial replacement
    Wissink, MSB
    Feijen, J
    POLYMER BASED SYSTEMS ON TISSUE ENGINEERING, REPLACEMENT AND REGENERATION, 2002, 86 : 391 - 405
  • [4] Biofabrication of small diameter tissue-engineered vascular grafts
    Weekes, Angus
    Bartnikowski, Nicole
    Pinto, Nigel
    Jenkins, Jason
    Meinert, Christoph
    Klein, Travis J.
    ACTA BIOMATERIALIA, 2022, 138 : 92 - 111
  • [5] In Vivo Imaging of Tissue-Engineered Grafts Within Pulmonary Artery of a Growing Large Animal Model
    Bates, Novella M.
    Fallon, Meghan E.
    Hinds, Monica T.
    JACC-BASIC TO TRANSLATIONAL SCIENCE, 2022, 7 (03): : 220 - 222
  • [6] In Vivo Applications of Electrospun Tissue-Engineered Vascular Grafts: A Review
    Rocco, Kevin A.
    Maxfield, Mark W.
    Best, Cameron A.
    Dean, Ethan W.
    Breuer, Christopher K.
    TISSUE ENGINEERING PART B-REVIEWS, 2014, 20 (06) : 628 - 640
  • [7] Tissue-engineered arterial grafts: long-term results after implantation in a small animal model
    Mirensky, Tamar L.
    Nelson, Gregory N.
    Brennan, Matthew P.
    Roh, Jason D.
    Hibino, Narutoshi
    Yi, Tai
    Shinoka, Toshiharu
    Breuer, Christopher K.
    JOURNAL OF PEDIATRIC SURGERY, 2009, 44 (06) : 1127 - 1133
  • [8] The effect of chronic kidney disease on tissue formation of in situ tissue-engineered vascular grafts
    Besseling, Paul J. J.
    Krebber, Merle M. M.
    Fledderus, Joost O. O.
    Teraa, Martin
    den Ouden, Krista
    van de Kaa, Melanie
    de Bree, Petra M. M.
    Serrero, Aurelie
    Bouten, Carlijn V. C.
    Dankers, Patricia Y. W.
    Cox, Martijn A. J.
    Verhaar, Marianne C. C.
    APL BIOENGINEERING, 2023, 7 (02)
  • [9] Acellular Small-Diameter Tissue-Engineered Vascular Grafts
    Li, Zhen
    Li, Xinda
    Xu, Tao
    Zhang, Lei
    APPLIED SCIENCES-BASEL, 2019, 9 (14):
  • [10] Functional smalt-diameter human tissue-engineered arterial grafts in an immunodeficient mouse model - Preliminary findings
    Nelson, Gregory N.
    Mirensky, Tamar
    Brennan, Matthew P.
    Roh, Jason D.
    Yi, Tai
    Wang, Yinong
    Breuer, Christopher K.
    ARCHIVES OF SURGERY, 2008, 143 (05) : 488 - 494